Rethinking Cancer Medicine – a lecture by Dr. Janowitz
CSHL associate professor Tobias Janowitz, M.D., Ph.D. presents to the Cold Spring Harbor Laboratory Association "how tumors interact with the entire body" ...
Cold Spring Harbor Laboratory
Best of the Day: ASCO 2016 - GI Malignancies
New Immuno- and targeted therapeutics are reforming diagnostics, first- and second-line therapies, treatment protocols, and sequencing strategies across ...
ImedexCME
Point Counterpoint: Early Chemotherapy is Better
Dr. Daniel P. Petrylak and Dr. Michael S. Cookson presented "Point-Counterpoint: Early Chemotherapy is Better" at the 27th annual International Prostate ...
Grand Rounds in Urology
Metastatic prostate cancer - Interpreting negative trial results
Prof Stephane Oudard (Georges Pompidou Hospital, Paris, France) and Prof Noel Clarke (The Christie Hospital, Manchester, UK) discuss the implications of ...
ecancer
ESMO 2017 Highlights in Genitourinary Cancers: Treatment Advances
Bernard Escudier explains the results from the practice changing CheckMate 214 study that supports the use of combined nivolumab plus ipilimumab as a ...
European Society for Medical Oncology
MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients
Martine Piccart, MD, PhD & Head of the Medicine Department at the Jules Bordet Institute and Co-Founder of the Breast International Group (BIG) discusses ...
MDLinx
Adjuvant therapy: Current practice and emerging strategies
In this presentation from the 22nd Annual Perspectives in Thoracic Oncology, Dr. Tracey L. Evans discusses current practices and emerging strategies for ...
ImedexCME
Breast Cancer 360: Genomic Testing and New Directions for Treatment
During this presentation Dr. Nikhil Wagle explains what genomic testing is, how it's used in breast cancer, where to get it and how to pay for it. We'll explain how ...
Living Beyond Breast Cancer
Update 5: Updates in the Management of Rectal Cancer
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational ...
ImedexCME
How Molecular Pathology Facilitates the Personalization of Cancer Treatment | MSK
Neuropathologist Jason Huse discusses personalized medicine and how studying the molecular pathology of patients' tumors can lead to new therapies.
Memorial Sloan Kettering
The Clinical Potential of Novel PARP Inhibitors for Improved Management of Epithelial Ovarian Cancer
The Clinical Potential of Novel Poly ADP-Ribose Polymerase Inhibitors for Improved Management of Epithelial Ovarian Cancer, a satellite symposium held in ...
ImedexCME
Rectal Cancer Surgery Outcomes Enhanced with Colorectal Surgeons - Mayo Clinic
A new Mayo Clinic study shows that the type of surgeon and the type of hospital have a significant influence on long-term outcomes for patients who undergo ...
Mayo Clinic
Live Webchat: What's New in Metastatic Breast Cancer Treatment and Research
The Susan F. Smith Center for Women's Cancers at Dana-Farber is partnering with the Metastatic Breast Cancer Network for a live video webchat on the latest ...
Dana-Farber Cancer Institute
Prostate Cancer: Clinical Guidelines, Novel Therapies, and Therapeutic Uncertainty
This webcast features a presentation by Dr. Atish D. Choudhury that examines the latest clinical safety and efficacy data surrounding next-generation ...
ImedexCME
Current Status of Adjuvant Therapy for NSCLC
The 17th European Congress: Perspectives in Lung Cancer, held from 4-5 March 2016 in Prague, provided attendees with valuable information regarding new ...
ImedexCME
ASCO 2008: Cetuximab for metastatic colorectal cancer (mCRC)
Professor Carsten Bokemeyer discussing Cetuximab for metastatic colorectal cancer (mCRC).
ecancer
Advances in Prostate Cancer Chemotherapy: The Dawn of a New Era
Advances in Prostate Cancer Chemotherapy: The Dawn of a New Era by Richard Sowery, MSc, MD, FRCSC, Uro-Oncology Fellow, Department of Urological ...
UBC Urology Rounds
MSI Status and Immunotherapy in Advanced Colorectal Cancer
Panelists John Marshall, MD; Johanna Bendell, MD; Tanios Bekaii-Saab, MD; and Alan P. Venook, MD, outline the clinical utility of microsatellite instability status ...
OncLiveTV
Cardiac Amyloidosis Interpretation Best Practices
Presented by Scott Jerome, DO, FACC, FASNC, FSCCT, this webinar is designed to: illustrate the importance of quality images for optimal cardiac amyloidosis ...
Intersocietal Accreditation Commission
Chemotherapy for BRCA-Mutated Prostate Cancer
Doctors discuss the use of platinum-based chemotherapy for advanced prostate cancer in patients who carry BRCA1 and BRCA2 mutations and the emerging ...
OncLiveTV
Precision Medicine in Oncology: Monitoring Cancer Using a Urine Sample | Antonius Schuch | TEDxUCSD
Antonius Schuch challenges and shows us how precise analytical techniques can help us address the needs of healthcare and improve the quality of life.
TEDx Talks
Clinical Trials During and After Breast Cancer
Breast Cancer Medical Oncologist and Co-Director of the Johns Hopkins Breast Cancer Program Dr. Vered Stearns discusses the importance of clinical trials ...
Johns Hopkins Medicine
When To See a Medical Oncologist for Advanced Thyroid Cancer.
When To See a Medical Oncologist for Advanced Thyroid Cancer. In this new 9-minute Video, Keith C. Bible, M.D., Ph.D., of Mayo Clinic discusses advanced ...
ThyCa: Thyroid Cancer Survivors' Association, Inc.
TRACO 2015: Breast Cancer - Clinical Trials
TRACO 2015: Breast Cancer - Clinical Trials Air date: Monday, September 28, 2015, 4:00:00 PM Category: TRACO Runtime: 02:01:58 Description: Breast ...
NIH VideoCast
Treatment Approaches for Pancreatic Cancer
This webinar covers standard treatment approaches and clinical trials for pancreatic cancer. This webinar was recorded on January 27, 2016. The presenter is ...
Pancreatic Cancer Action Network
eRAPID: an eHealth intervention during chemotherapy
Galina Velikova, BMBS, RCP, PhD, University of Leeds, UK, discusses the phase III eRAPID (electronic patient self-Reporting of Adverse-events: Patient ...
VJOncology
Lung Cancer Webchat: What You Need to Know About Treatment and Research
Geoffrey Oxnard, MD, discusses the latest in lung cancer treatment and research, including new developments in immunotherapy and targeted therapy.
Dana-Farber Cancer Institute
Gastric Cancer Debate: Should Radiotherapy Be Included as Part of Adjuvant Therapy? - No
In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Florian Lordick argues against the use of radiotherapy as part of adjuvant ...
ImedexCME
Prediction of Response to Anthracycline-Based Chemotherapy in Early Breast Cancer
Richard D. Kennedy This presentation used cDNA-micoarray-based transcriptional data from Fanconi Anemia patients, BRCA ½ mutant breast cancer patients ...
AlphaMed Press
Colorectal Cancer: FOLFOX versus FOLFIRI in the MAVERICC Trial
The panelists, John L. Marshall, MD; Johanna Bendell, MD; Charles S. Fuchs, MD, MPH; Tanios Bekaii-Saab, MD; and Richard Kim, MD, discuss how they ...
OncLiveTV
Immunotherapy + Chemotherapy in Nonsquamous NSCLC
Experts provide considerations surrounding the use of chemoimmunotherapy regimens as first-line treatment in patients with advanced nonsquamous ...
OncLiveTV
Penile Cancer: An Update on Epidemiology, Diagnosis and Treatments
Penile Cancer: An Update on Epidemiology, Diagnosis and Treatments by Dr. Khatereh Aminoltejari, Resident, PGY4 Presented on May 13, 2020.
UBC Urology Rounds
The Power and Promise of Cancer Research: Presented at ASCO Annual Meeting 2018
On June 2, 2018, National Cancer Institute (NCI) Director Norman E. Sharpless, M.D. presented at the 2018 American Society of Clinical Oncology (ASCO) ...
National Cancer Institute
Dr. Dawn Lemanne - 'Carbohydrate Restriction in Cancer Therapy'
Dr. Dawn Lemanne is a Stanford-trained, board-certified integrative and medical oncologist. Dr. Lemanne has published in peer-reviewed journals and has ...
Low Carb Down Under
Expert Perspectives: Chemotherapy-Induced Nausea & Vomiting
This Expert Perspectives activity highlights the therapeutic options and practice guidelines discussed during the Best Practices and Emerging Treatment ...
ImedexCME
Clarke - Therapeutic Drug Monitoring TDM) in Cancer Chemotherapy
Watch on LabRoots at: http://labroots.com/user/webinars/details/id/110 Many drugs currently used for anti-cancer therapy demonstrate significant inter-individual ...
LabRoots
Chemotherapy: Mastering the Challenges, Part 3
UCSFMedicalCenter
ASCO's First-Ever Clinical Trial: The TAPUR Study
The Targeted Agent and Profiling Utilization Registry (TAPUR) study is evaluating molecularly targeted cancer drugs and collecting data on clinical outcomes to ...
ASCOcancer
Latest Advancements in Breast Cancer
The Stanford Women's Cancer Center recognized October as National Breast Cancer Awareness Month by bringing together several specialists to discuss the ...
Stanford Health Care
What's Happening with Cancer Genomics?
Dr. James Ford, a Stanford Cancer Institute researcher and oncologist, addressed clinical research in cancer genomics and how it is changing the way cancers ...
Stanford Health Care
Breast Cancer Diagnosis and Treatment - Stanley Lipkowitz
February 3, 2012 - The Genomics in Medicine Lecture Series More: http://www.genome.gov/27546022.
National Human Genome Research Institute
CME Preview: Clinical Pharmacogenomics: A Case-Based Approach for your Practice 2019
The use of pharmacogenomics in patient care has seen rapid growth due to the recent emergence of pharmacogenomics science and the decline in test pricing.
Mayo Clinic
